During the past decade, Taichung Veterans General Hospital conducted 299 clinical trials. In the 10-year time frame, 299 clinical trials started and 99 clinical trials were completed, i.e. on average, 33.1% percent of trials that started reached the finish line to date. In the past 5 years, 161 clinical trials started and 66 clinical trials were completed. i.e. 41% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taichung Veterans General Hospital" #1 sponsor was "Taichung Veterans General Hospital" with 67 trials, followed by "Pfizer" with 29 trials sponsored, "Janssen Research & Development, LLC" with 18 trials sponsored, "Boehringer Ingelheim" with 17 trials sponsored and "Eli Lilly and Company" with 17 trials sponsored. Other sponsors include 266 different institutions and companies that sponsored additional 136 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taichung Veterans General Hospital" #1 collaborator was "Taichung Veterans General Hospital" with 17 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 10 trials as a collaborator, "National Taiwan University Hospital" with 9 trials as a collaborator, "Chang Gung Memorial Hospital" with 8 trials as a collaborator and "Taipei Veterans General Hospital, Taiwan" with 8 trials as a collaborator. Other collaborators include 157 different institutions and companies that were collaborators in the rest 105 trials.

According to Clinical.Site data, the most researched conditions in "Taichung Veterans General Hospital" are "Carcinoma, Non-Small-Cell Lung" (11 trials), "Non-Small Cell Lung Cancer" (11 trials), "Non-small Cell Lung Cancer" (11 trials), "Hepatocellular Carcinoma" (9 trials) and "Hemophilia A" (8 trials). Many other conditions were trialed in "Taichung Veterans General Hospital" in a lesser frequency.

Most popular intervention types in "Taichung Veterans General Hospital" are "Drug" (319 trials), "Other" (36 trials), "Biological" (33 trials), "Device" (19 trials) and "Dietary Supplement" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (75 trials), "Cisplatin" (17 trials), "Carboplatin" (14 trials), "Pemetrexed" (13 trials) and "Pembrolizumab" (11 trials). Other intervention names were less common.

The vast majority of trials in "Taichung Veterans General Hospital" are 373 trials for "All" genders, 23 trials for "Male" genders and 22 trials for "Female" genders.

Currently, there are 160 active trials in "Taichung Veterans General Hospital". 2 are not yet recruiting, 85 are recruiting, 72 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 176 completed trials in Taichung Veterans General Hospital, 1 suspended trials, and 35 terminated clinical trials to date.

Out of the total trials that were conducted in Taichung Veterans General Hospital, 29 "Phase 1" clinical trials were conducted, 92 "Phase 2" clinical trials and 179 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 49 trials, and there were also 33 trials that are defined as “Not Applicable".

Taichung Veterans General Hospital has several departments that took part in Clinical trials: "Division of Endocrinology and Metabolism in Taichung Veterans General Hospital" - 10 trials, "Taichung Veterans General Hospital; Division of Urology" - 7 trials, "Taichung Veterans General Hospital; Dept of Surgery" - 5 trials, "Taichung Veterans General Hospital; Dept of Internal Medicine" - 5 trials, "Taichung Veterans General Hospital, Department of Surgery" - 2 trials, "Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital" - 2 trials